Find investors who align with your industry, stage, and vision. Unlock Mel Billingsley’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.
Get connected with all investors todayMel Billingsley is a Venture Capital, Incubator, Government Office, Private Equity Firm based in Harrisburg, Pennsylvania, United States with a diverse investment portfolio that includes companies such as NanoHorizons, Immunomic Therapeutics, INRange Systems, SoftGenetics, Chaperone Technologies, MacuLogix, Novasentis, Micro Interventional Devices, Xbio Systems, INDIGO Biosciences, . Over time, Mel Billingsley has demonstrated experience in supporting a range of businesses across various sectors.
While it is not publicly confirmed whether Mel Billingsley is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.
Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wearables, Genetics, Wellness, Women Founded, Healthcare Innovation, Life Science, Engineering, Portfolio Management, Medical Technologies, Venture Fundraising, Software, Manufacturing, Biotechnology, Healthcare IT, Medical Devices, Market Research, Genomics, Consulting, Hardware, Technology Transfer, Health Diagnostics, Medical, Sensors, B2B, Therapeutics, Health Tech, Pharmaceuticals, Healthcare Technology may find it worthwhile to explore potential connections with Mel Billingsley, as their portfolio suggests a familiarity and interest in this area.
Understanding Mel Billingsley’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.
Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.
Find the perfect investors today